化学科研者一站式服务平台


  • SNX 2112; 2-[(反式-4-羟基环己基)氨基]-4-[4,5,6,7-四氢-6,6-二甲基-4-氧代-3-(三氟甲基)-1H-吲唑-1-基]苯甲酰胺

    PF-04928473

化合物简介

SNX-2112 is a selective heat shock protein 90 (Hsp90) inhibitor which can exert a potent anticancer activity. Studies demonstates that SNX-2112 can exhibit a potent anticancer activity against B16 melanoma cells both in vitro and in vivo, by inhibiting cell proliferation and inducing cell cycle arrest and apoptosis in a mechanism dependent on the degredation of Hsp90 client proteins.

基本信息

CAS:908112-43-6
中文别名
英文别名:4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide;SNX-2112;4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((4-hydroxycyclohexyl)amino)benzamide;
分子式:C23H27F3N4O3
分子量:464.481
精确质量:464.204
Psa:110.24
Logp:4.6338

编号系统

MDL号:MFCD16038907

物化性质

密度:1.5±0.1g/cm3
沸点:619.8±55.0°Cat760mmHg
熔点:265-266℃
闪点:328.6±31.5°C
外观性状:粉末
蒸汽压:0.0±1.9mmHgat25°C
折射率:1.638
储存条件:-20℃

安全信息

生产方法及用途

合成路线

上游原料

下游产品

图谱

1H NMR : Predict


13C NMR : Predict


加载中...